"Skin Research Institute, located at our dermatology office in Coral Gables, has a complete state-of-the-art research infrastructure solely dedicated to clinical trials. With a specialized staff of research professionals, we perform clinical research on protocols, cosmetic ingredients and treatments. Additionally, physicians develop their own research protocols to evaluate the efficacy of new therapies. Skin Research Institute performs dozens of clinical trials each year. The Institute was instrumental in the FDA approval of BOTOX® Cosmetic, Dysport®, Restylane®, Perlane®, Sculptra® and several other cosmetic products now available. Whether it is a pharmaceutical product or device, SRI has earned the trust of sponsors and patients."

During the past decade, Skin Research Institute conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 14 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Skin Research Institute" #1 sponsor was "Galderma R&D" with 7 trials, followed by "Revance Therapeutics, Inc." with 6 trials sponsored, "Allergan" with 4 trials sponsored, "Medy-Tox" with 3 trials sponsored and "Neothetics, Inc" with 3 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Skin Research Institute" #1 collaborator was "Database Integrations, Inc." with 1 trials as a collaborator, "Hugel" with 1 trials as a collaborator, "Instat Consulting, Inc." with 1 trials as a collaborator, "Paidion Research, Inc." with 1 trials as a collaborator and "Q-Med Scandinavia, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Skin Research Institute" are "Lateral Canthal Lines" (8 trials), "Glabellar Lines" (4 trials), "Crow's Feet" (3 trials), "Facial Wrinkles" (3 trials) and "Central Abdominal Bulging" (2 trials). Many other conditions were trialed in "Skin Research Institute" in a lesser frequency.

Most popular intervention types in "Skin Research Institute" are "Drug" (22 trials), "Device" (13 trials), "Biological" (7 trials), "Other" (5 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Botulinum Toxin Type A" (4 trials), "LIPO-202" (3 trials), "MT10109L" (3 trials) and "Vehicle" (2 trials). Other intervention names were less common.

The vast majority of trials in "Skin Research Institute" are 39 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Skin Research Institute". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Skin Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Skin Research Institute, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 8 trials that are defined as “Not Applicable".